Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 81.1B | 81.1B | 87.8B | 90.0B |
Cost of revenue | 62.6B | 63.8B | 67.4B | 69.8B |
Gross profit | 18.5B | 17.2B | 20.4B | 20.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 2.5B | 2.6B | 2.3B | 2.6B |
Other operating expenses | 64M | 186M | 339M | 153M |
Operating income | 9.8B | 7.8B | 11.0B | 10.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 205M | 297M | 207M | 271M |
Other income expense | 2.0B | 2.3B | 2.2B | 3.0B |
Pretax income | 11.6B | 9.8B | 13.0B | 13.7B |
Tax provision | 3.6B | 1.9B | 4.1B | 4.1B |
Net income | 8.0B | 8.0B | 9.0B | 9.6B |
Basic EPS | 8.8 | 8.6 | 9.6 | 10.7 |
Diluted EPS | 8.8 | 8.6 | 9.6 | 10.7 |
Basic average shares | 874.4M | 884.9M | 896.9M | 863.6M |
Diluted average shares | 874.4M | 884.9M | 896.9M | 863.6M |
EBITDA | 17.5B | 16.7B | 19.5B | 19.7B |
Net income from continuing op. | 8.0B | 8.0B | 9.0B | 9.6B |
Minority interests | -320M | -345M | -361M | -331M |
Preferred stock dividends | — | — | — | — |